Filter Results:
- Full text PDF available (11)
Publication Year
2001
2018
- This year (9)
- Last 5 years (16)
- Last 10 years (18)
Publication Type
Co-author
Journals and Conferences
Learn More
- Shengnan Yu, Anping Li, +4 authors Kongming Wu
- Journal of hematology & oncology
- 2017
The chimeric antigen receptor T (CAR-T) cell therapy is a newly developed adoptive antitumor treatment. Theoretically, CAR-T cells can specifically localize and eliminate tumor cells by interacting… (More)
- Hanxiao Xu, Shengnan Yu, +4 authors Kongming Wu
- Journal of hematology & oncology
- 2017
Uncontrolled cell division is the hallmark of cancers. Full understanding of cell cycle regulation would contribute to promising cancer therapies. In particular, cyclin-dependent kinases 4/6… (More)
- Wen-Hua Chen, Jie Wang, +6 authors Ya Peng
- Surgical neurology
- 2009
BACKGROUND
Sixteen-row multislice CT has great potential for use in vascular studies. The aim of the study was to assess the diagnostic accuracy of 16-row multislice CTA in detecting intracranial… (More)
- Kongju Wu, Shengnan Yu, Qian Liu, Xianguang Bai, Xinhua Zheng, Kongming Wu
- OncoTargets and therapy
- 2017
As a CXC-type chemokine, ENA78/CXCL5 is an important attractant for granulocytes by binding to its receptor CXCR2. Recent studies proved that CXCL5/CXCR2 axis plays an oncogenic role in many human… (More)
- Shengnan Yu, Anping Li, +6 authors Kongming Wu
- Journal of hematology & oncology
- 2017
Cancer immunotherapy is the most exciting advancement in cancer therapy. Similar to immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T), bispecific antibody (BsAb) is attracting… (More)
- Qian Liu, Shengnan Yu, Anping Li, Hanxiao Xu, Xinwei Han, Kongming Wu
- Tumour biology : the journal of the International…
- 2017
Immunotolerance is one of the hallmarks of malignant tumors. Tumor cells escape from host immune surveillance through various mechanisms resulting in tumor progression and therapeutic resistance.… (More)
- Hanxiao Xu, Shengnan Yu, +4 authors Kongming Wu
- Scientific Reports
- 2017
Dachshund homolog 1 (DACH1), a key cell fate determination factor, contributes to tumorigenesis, invasion, metastasis of human breast neoplasm. However, the exact molecular mechanisms for the… (More)
- Qian Liu, Shengnan Yu, Weiheng Zhao, Shuang Qin, Qian Chu, Kongming Wu
- Molecular Cancer
- 2018
Tyrosine kinase inhibitors (TKIs)-treatments bring significant benefit for patients harboring epidermal growth factor receptor (EGFR) mutations, especially for those with lung cancer. Unfortunately,… (More)
- Qian Liu, Anping Li, +5 authors Kongming Wu
- Journal of hematology & oncology
- 2018
BACKGROUND
C-X-C motif ligand 8 (CXCL8), known as a proinflammatory chemokine, exerts multiple effects on the proliferation, invasion, and migration of tumor cells via the autocrine or paracrine… (More)
- Shengnan Yu, Qian Liu, +4 authors Kongming Wu
- Experimental hematology & oncology
- 2017
HER2-targeted immunotherapy consists of monoclonal antibodies (e.g. trastuzumab, pertuzumab), bispecific antibodies (e.g. MM-111, ertumaxomab) and activated T cells armed with anti-HER2 bispecific… (More)